单中心186例早期胃癌区域淋巴结转移特征与预后分析
作者:
通讯作者:
作者单位:

作者简介:

张亚铭, Email: zhangyaming2014@163.com

基金项目:


Characteristics of lymph metastasis and prognostic analysis of 186 patients with early gastric cancer from a single center
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的:探讨早期胃癌(EGC)的临床病理特征和淋巴结转移的关系以及淋巴结转移对EGC患者预后的影响。
    方法:对安徽医科大学附属安庆医院2010年10月—2018年12月手术治疗的186例EGC患者临床资料进行回顾性分析。
    结果:186例EGC患者中,17例(9.1%)出现区域淋巴结转移。单因素分析显示,黏膜下癌(T1b)患者淋巴结转移率高于黏膜内癌患者(T1a)(15.1% vs. 4.2%,χ2=5.177,P=0.023);病灶最大径>2 cm患者淋巴结转移率高于病灶最大径≤2 cm患者(14.3% vs. 5.5%,χ2=4.190,P=0.041);伴有脉管浸润患者淋巴结转移率高于无脉管浸润患者(50.0% vs. 6.8%,χ2=21.247,P=0.000);总淋巴结清扫≥15枚患者淋巴结转移率高于淋巴结清扫<15枚患者(12.5% vs. 0,χ2=6.879,P=0.009);患者性别、年龄、肿瘤部位、大体类型、分化程度、手术方式与淋巴结转移均无明显关系(均P>0.05)。多因素分析结果显示,伴有脉管浸润是EGC淋巴结转移的独立危险因素(RR=6.886,95% CI=1.399~33.898,P=0.018)。173例(93.0%)患者具有完整随访资料,随访时间2~95个月。全组EGC患者3、5年累计生存率分别为96.1%、92.4%,其中无淋巴结转移患者分别为97.1%、95.5%,有淋巴结转移患者分别87.5%、65.6%,尽管前生存率优于后者,但差异无统计学意义(χ2=2.478,P=0.115)。
    结论:黏膜下层浸润、病灶最大径>2 cm、伴有脉管浸润的EGC患者有更高的区域淋巴结转移风险,因此对EGC要进行规范的淋巴结清扫以准确的判断术后病理分期及决定后续治疗。淋巴结转移对EGC患者预后的影响还需进一步的长期随访研究确定。

    Abstract:

    Objective: To investigate the relationship between clinicopathologic features and lymph node metastasis in early gastric cancer (EGC) and the influence of lymph node metastasis on prognosis of EGC patients.
    Methods: The clinical data of 186 EGC patients who underwent surgical treatment from October 2010 to December 2018 in Anqing Hospital Affiliated to Anhui Medical University were retrospectively analyzed.
    Results: Of the 186 EGC patients, regional lymph node metastases occurred in 17 cases (9.1%). Univariate analysis showed that the lymph node metastasis rate in patients with submucosal invasion (T1b) was higher than that in patients with intramucosal cancer (T1a) (15.1% vs. 4.2%, χ2=5.177, P=0.023), in patients with the maximal lesion diameter >2 cm was higher than in patients with the maximal lesion diameter ≤2 cm (14.3% vs. 5.5%, χ2=4.190, P=0.041), in patients with vascular invasion was higher than that in patients without vascular invasion (50.0% vs. 6.8%, χ2=21.247, P=0.000), and in patients with total lymph node dissection ≥15 was higher than that in patients with lymph node dissection <15 (12.5% vs. 0, χ2=6.879, P=0.009); no significant relationships were noted between lymph node metastasis and the variables that included sex, age, tumor site, gross type of tumor, degree of differentiation, and surgical method (all P>0.05). Multivariate analysis showed that vascular infiltration was an independent risk factor for EGC lymph node metastasis (RR=6.886, 95% CI=1.399–33.898, P=0.018). Complete follow-up data were available in 173 patients (93.0%), and the follow-up time ranged from 2 to 95 months. The 3- and 5-year survival rates in the whole group were 96.1% and 92.4%, which were 97.1% and 95.5% in patients without lymph node metastasis and 87.5% and 65.6% in patients with lymph node metastasis, respectively. Although the survival in the former was better than that in the latter, the difference did not reach a statistical significance (χ2=2.478, P=0.115).
    Conclusion: EGC patients with submucosal invasion, maximal lesion diameter >2 cm or vascular infiltration have a higher risk of regional lymph node metastasis, so standardized lymph node dissection should be performed for accurate determination of postoperative pathological stage and decision of subsequent treatment. The influence of lymph node metastasis on the prognosis of EGC patients needs clarification by further long-term follow-up studies.

    参考文献
    相似文献
    引证文献
引用本文

周潮平, 汤代彬, 汪大田, 高斌, 马军, 袁建伟, 蒋鹏, 黄利娟, 张亚铭.单中心186例早期胃癌区域淋巴结转移特征与预后分析[J].中国普通外科杂志,2019,28(10):1221-1227.
DOI:10.7659/j. issn.1005-6947.2019.10.009

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2019-05-31
  • 最后修改日期:2019-09-17
  • 录用日期:
  • 在线发布日期: 2019-10-25